New pathogenic hypotheses for spondyloarthropathies

Joint Bone Spine

Volumn 69, Issue 2, 2002, Pages 114-122

  Berthelot, Jean Marie ^a   Glemarec, Joëlle ^a   Guillot, Pascale ^a   Laborie, Yves ^a   Maugars, Yves ^a  

^a HÔTEL DIEU   (France)

Author keywords

Chaperones; HLA B27; Pathogenesis; Spondyloarthropathy

Indexed keywords

BACTERIAL ANTIGEN; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; CHAPERONE; CYTOKINE; HLA B27 ANTIGEN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

DENDRITIC CELL; DISEASE ASSOCIATION; HLA TYPING; HUMAN; MACROPHAGE ACTIVATION; PATHOGENESIS; REVIEW; RHEUMATIC DISEASE; SPONDYLOARTHROPATHY;

EID: 0036235455     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(02)00371-8     Document Type: Short Survey

References (67)

1. Jekyll and Hyde: The transformation of HLA-B27
2. The effects of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis
3. The genetics of des spondyloarthropathies
4. Inflammatory disease in HLA-B27 transgenic rats
5. Ankylosing spondylitis in monozygotic twins: Studies on immunological parameters
6. HLA-B27 and immunogenetics of spondylarthropathies
7. Reiter's syndrome associated with HLA-B51
8. Genome-wide screen for susceptibility loci in ankylosing spondylitis
9. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative caucasian and mexican Mestizo patients with ankylosing spondylitis
10. Animal models and in vitro models for the study of aetiopathogenesis of the spondylarthropathies. Baillieres
11. Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis
12. Reactive arthritis after Salmonella among medical doctors - Study of an outbreak
13. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease
14. Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis
15. Micro-organismes impliqués dans les arthrites réactionnelles
16. Evasion of host cell defense mechanisms by pathogenic bacteria
17. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease
18. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human b2microglobulin transgenic rats
19. Inhibition of murine splenic and mucosal lymphocyte function by enteric products
20. Persistent Chlamydia trachomatis infections resist apoptotic stimuli
21. Ankylosing spondylitis: Time to focus on ankylosis
22. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment
23. Animal models of the spondylarthropathies
24. Host cytokine response and resistance to Salmonella infection
25. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta-2 microglobulin: A model of human spondylarthropathies
26. Presentation of HLA class I-derived peptides: Potential involvement in allo-recognition and HLA-B27-associated arthritis
27. HLA-B27 misfolding and spondylarthropathies: Not so groovy after all?
28. Cutting edge: HLA-B27 can form a novel beta-2-microglobulin-free heavy chain homodimer structure
29. The role of HLA-B27 in spondyloarthritis
30. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondylarthropathies
31. An immunosuppressive and anti-inflammatory HLA class I-derived peptide binds vascular cell adhesion molecule-1
32. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules
33. Polymorphism of HLA-B27 and association with disease
34. Cytotoxic T-cell mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat
35. A subset of HLA-B27 molecules contains peptides much longer than nonamers
36. Alteration of HLA-B27 peptide presentation after injection of transfected murine L cells by Shigella flexneri
37. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinavise bacteria
38. HLA-B27 modulates intracellular survival of salmonella enteridis in human monocytic cells
39. HLA-B27 modulates the survival of Salmonella enteridis in transfected L cells possibly by impaired nitric oxide production
40. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Screening of synovial fluid samples of patients with spondylar-thropathies and other arthritides
41. Viability of inapparent synovial Chlamydia trachomatis in patients with Reiter's syndrome/reactive arthritis (RA)
42. Chlamydia rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis
43. Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease
44. Transient loss of HLA B27
45. False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction
46. Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis
47. Yersinia enterocolitica serotype O: 3 Alters the expression of serologic HLA-B27 epitopes on human monocytes
48. Identification and characterization of a new latent transforming growth-factor-beta-binding protein, LTBP-4
49. A novel role for TGF-beta and IL-10 in the induction of immune privilege
50. Anti-and pro-inflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease
51. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis
52. TGF-beta in infections and infectious diseases
53. Effect of transforming growth factor beta on experimental Samonella typhimurium infection in mice
54. Antibiotic trials in reactive arthritis
55. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study
56. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis
57. Double-blind, placebo-controlled study of three months treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
58. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro
59. Growth factor and cytokine gene expression in mechanically strained human osteoblast-like cells: Implications for distraction osteogenesis
60. Atypical clinical presentation of ankylosing spondylitis
61. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo
62. Interleukin-10 does not affect phagocytosis of particulate antigen by bone-marow-derived dendritic cells but does impair antigen presentation
63. In vitro induction of the expression of multiple IgA isotype genes in rabbit B cells by TGF-beta and IL-2
64. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis
65. Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis
66. Transgenic mice expressing a truncated Peromyscus leucopus TNF-alpha gene manifest an arthritis resembling ankylosing spondylitis
67. Role of autoreactive CD8+ T cells: Organ-specific autoimmune diseases: Insight from transgenic mouse models